The Pharmacy and Medicines Regulatory Authority (PMRA) is informing healthcare professionals, licensed pharmaceutical importers, wholesalers, retail pharmacies, healthcare facilities, and the general public that it has been made aware of an official regulatory recall notice issued by the Medicines Control Authority of Zimbabwe (MCAZ) via Circular No. 22 of 2026, dated 7th September 2026.
The MCAZ notice announces a Class II recall up to retail level for specified batches of Nifedipine 10mg Tablets, Levodopa/ Carbidopa 100mg/25mg Tablets and Levodopa/ Carbidopa 250mg/25mg Tablets manufactured by Remedica Ltd of Cyprus. The recall follows confirmed out-of- specification results during ongoing stability testing of the products.
Read full notice here.